Bradford Crutchfield is Chief Commercial Officer of 10x Genomics, Inc.. Currently has a direct ownership of 97,237 shares of TXG, which is worth approximately $2.15 Million. The most recent transaction as insider was on May 23, 2022, when has been sold 286 shares (Class A Common Stock) at a price of $48.76 per share, resulting in proceeds of $13,945. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.2K
0% 3M change
0% 12M change
Total Value Held $2.15 Million

BRADFORD CRUTCHFIELD Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2022
SELL
Open market or private sale
$13,945 $48.76 p/Share
286 Reduced 0.29%
97,237 Class A Common Stock
May 13 2022
BUY
Open market or private purchase
$6,397 $40.49 p/Share
158 Added 0.16%
97,523 Class A Common Stock
Feb 22 2022
SELL
Open market or private sale
$22,637 $78.6 p/Share
288 Reduced 0.29%
97,365 Class A Common Stock
Feb 15 2022
SELL
Open market or private sale
$1,617,210 $95.13 p/Share
17,000 Reduced 14.83%
97,653 Class A Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 12.91%
114,653 Class A Common Stock
Jan 12 2022
SELL
Open market or private sale
$2,066,010 $121.53 p/Share
17,000 Reduced 14.83%
97,653 Class A Common Stock
Jan 12 2022
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 12.91%
114,653 Class A Common Stock
Dec 21 2021
BUY
Exercise of conversion of derivative security
$170,346 $3.12 p/Share
54,598 Added 35.86%
97,653 Class A Common Stock
Dec 13 2021
SELL
Open market or private sale
$2,379,830 $139.99 p/Share
17,000 Reduced 28.31%
43,055 Class A Common Stock
Dec 13 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 22.06%
60,055 Class A Common Stock
Nov 22 2021
SELL
Open market or private sale
$41,695 $148.38 p/Share
281 Reduced 0.65%
43,055 Class A Common Stock
Nov 12 2021
SELL
Open market or private sale
$2,815,370 $165.61 p/Share
17,000 Reduced 28.18%
43,336 Class A Common Stock
Nov 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 21.98%
60,336 Class A Common Stock
Oct 12 2021
SELL
Open market or private sale
$2,677,670 $157.51 p/Share
17,000 Reduced 28.18%
43,336 Class A Common Stock
Oct 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 21.98%
60,336 Class A Common Stock
Sep 13 2021
SELL
Open market or private sale
$2,986,900 $175.7 p/Share
17,000 Reduced 28.18%
43,336 Class A Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 21.98%
60,336 Class A Common Stock
Aug 23 2021
SELL
Open market or private sale
$43,700 $161.85 p/Share
270 Reduced 0.62%
43,336 Class A Common Stock
Aug 12 2021
SELL
Open market or private sale
$2,713,030 $159.59 p/Share
17,000 Reduced 28.05%
43,606 Class A Common Stock
Aug 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 21.91%
60,606 Class A Common Stock
Jul 12 2021
SELL
Open market or private sale
$3,201,780 $188.34 p/Share
17,000 Reduced 28.05%
43,606 Class A Common Stock
Jul 12 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 21.91%
60,606 Class A Common Stock
Jun 14 2021
SELL
Open market or private sale
$3,255,330 $191.49 p/Share
17,000 Reduced 28.21%
43,262 Class A Common Stock
Jun 14 2021
BUY
Exercise of conversion of derivative security
$19,720 $1.16 p/Share
17,000 Added 22.0%
60,262 Class A Common Stock
May 24 2021
SELL
Open market or private sale
$45,707 $162.66 p/Share
281 Reduced 0.65%
43,262 Class A Common Stock
BC

Bradford Crutchfield

Chief Commercial Officer
Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG